Your trusted local auto dealership would never sell you a used vehicle that employees knew had a hidden defect and was subject to a safety recall, right?
Equifax executives are unquestionably sweating.
As revealed in a recent Bloomberg article, there is a stark difference of opinion between health regulators at the U.S Food and Drug Administration and Pfizer, a global pharmaceutical company, regarding one of the latter's product offerings.
If the proverbial writing is on the wall for consumer product giant Johnson & Johnson, it doesn't paint a very rosy picture.
The "Circle of Five" is a catchy sounding string of words, something that might aptly go with an intrigue-driven movie thriller or spy novel.
Obviously, vehicle manufacturers want to be preoccupied with happy thoughts linked to massive product sales across the country.
Criminal and civil backlash have been an unremitting constant in the wake of initial stories that now go back several years concerning air bag defects on a massive global scale.
It seems reasonably logical to lead off today's blog post with the proverbial glass-half-full-or-empty query that often accompanies head-scratching realities.
General Motors' executives and shareholders have been decidedly unhappy for over a week now, in the wake of a U.S. Supreme Court action that essentially crushed hopes that the behemoth automaker might escape future liability that could potentially cost the company a flatly astronomical amount of money.
A 12% jump regarding select subject matter relating to America's children can be salutary, indeed, if it is linked with something like collectively improved test scores, an increased immunization rate, lower rates of family-based domestic violence or some other positive development.